ArticlePLoS pathogens2023

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.